Stephanie S. Okey's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 10,350 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 10,350 | 10,350 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,900 | 16,300 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Sale of securities on an exchange or to another person at price $ 54.00 per share. | 13 Mar 2025 | 5,000 | 8,867 (0%) | 0% | 54 | 270,000 | Common Stock |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 13,867 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2024 | 4,663 | 12,635 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 3,400 | 9,400 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.29 per share. | 28 Mar 2024 | 17,500 | 23,500 (0%) | 0% | 18.3 | 320,075 | Common Stock |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2024 | 17,500 | 0 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Sale of securities on an exchange or to another person at price $ 46.38 per share. | 28 Mar 2024 | 17,500 | 6,000 (0%) | 0% | 46.4 | 811,650 | Common Stock |
| PTC Therapeutics Inc | Stephanie Okey S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stephanie Okey S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 9,867 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 6,993 | 7,972 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 979 | 979 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 6,000 | 6,000 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 5,867 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Sale of securities on an exchange or to another person at price $ 51.62 per share. | 09 Aug 2022 | 2,296 | 1,867 (0%) | 0% | 51.6 | 118,522 | Common Stock |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 4,163 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 13 Aug 2021 | 1,650 | 963 (0%) | 0% | 40.1 | 66,094 | Common Stock |
| Crinetics Pharmaceuticals Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 1,650 | 2,613 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Sale of securities on an exchange or to another person at price $ 62.52 per share. | 08 Dec 2020 | 687 | 963 (0%) | 0% | 62.5 | 42,954 | Common Stock |